Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study
- Status
- TERMINATED
- Phase
- PHASE2
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).
- Status
- UNKNOWN
- Phase
- PHASE2
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
- Status
- TERMINATED
- Phase
- PHASE1
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Escalated Dose of Irinotecan in mCRC
- Status
- COMPLETED
- Phase
- NA
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2